文献速递艾滋病与性传播感染

血浆线粒体DNA水平与HIV-RNA负相关、与CD4计数正相关:或为HIV复制生物标志物

Plasma mitochondrial DNA levels are inversely associated with HIV-RNA levels and directly with CD4 counts: potential role as a biomarker of HIV replication.
PubMed 文献 · J Antimicrob Chemother · 2017-01-01

本研究纳入235例HIV感染者,用定量实时PCR检测血浆线粒体DNA(mtDNA)水平,并同步评估HIV-RNA和CD4+细胞计数。结果显示血浆mtDNA水平与HIV-RNA呈负相关(Spearman's rho -0.191,P=0.003),与CD4+计数呈正相关(Spearman's rho 0.131,P=0.046);在病毒学抑制患者中,完全抑制者mtDNA水平高于低水平病毒血症者。提示血浆mtDNA或可作为残余HIV复制的生物标志物。

要点

  • 血浆mtDNA水平与HIV-RNA负相关、与CD4+计数正相关。
  • 病毒学完全抑制者mtDNA水平高于低水平病毒血症者。
  • 血浆mtDNA或可反映残余HIV复制。

核心结论

  • 血浆mtDNA水平升高与较低的HIV-RNA水平和较高的CD4+细胞计数相关。
  • 在ART抑制的患者中,完全病毒学抑制(未检测到)者的mtDNA水平显著高于低水平病毒血症者。
  • 血浆mtDNA水平可能作为残余HIV复制的生物标志物。

研究设计与样本

  • 研究纳入在西班牙西北部一家参考医院随访的HIV感染者235例。
  • 从血浆样本中分离DNA,采用定量实时PCR检测mtDNA水平。
  • 在同一血样中评估HIV-RNA水平和CD4+细胞计数,并纳入流行病学和临床变量分析。

主要发现

  • 初治患者(31.9%)平均血浆mtDNA水平为217 ± 656 copies/μL,接受ART且病毒血症抑制者为364 ± 939 copies/μL(P=0.043)。
  • 在病毒学抑制者中,低水平病毒血症(LLV;HIV-RNA 20-200 copies/mL)平均mtDNA为149 ± 440 copies/μL,检测到但未定量(DNQ;HIV-RNA <20 copies/mL)为265 ± 723 copies/μL,未检测到(ND)为644 ± 1310 copies/μL。
  • 在病毒学抑制(LLV、DNQ和ND)患者中观察到线性趋势(P=0.006)。
  • ND患者mtDNA水平高于LLV患者(P=0.057)。
  • mtDNA水平与HIV-RNA水平呈负相关(Spearman's rho -0.191,P=0.003),与CD4+计数呈正相关(Spearman's rho 0.131,P=0.046)。

临床怎么用

  • 血浆mtDNA水平或可用于辅助评估ART患者的残余HIV复制。
  • 在病毒学抑制患者中,mtDNA水平差异可能提示残余复制程度不同。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate plasma mitochondrial DNA (mtDNA) levels among HIV-infected patients and its potential role as a biomarker of residual viral replication. METHODS: HIV-infected patients on follow-up at a reference hospital in north-west Spain were selected. DNA was isolated from plasma samples and mtDNA levels were assessed using a quantitative real-time PCR assay. HIV-RNA levels and CD4+ cell counts were evaluated in the same blood samples used for plasma mtDNA quantification. Epidemiological and clinical variables were included for the analysis. RESULTS: A total of 235 HIV-infected patients were included. Mean plasma mtDNA levels were 217 ± 656 copies/μL for naive (31.9%) and 364 ± 939 copies/μL for HIV-infected patients receiving ART and with suppressed viraemia (P = 0.043). Among the latter, mean plasma mtDNA levels were 149 ± 440 copies/μL for those with low-level viraemia (LLV; HIV-RNA 20-200 copies/mL), 265 ± 723 copies/μL for those with detected-not-quantified (DNQ) viraemia (HIV-RNA <20 copies/mL) and 644 ± 1310 copies/μL for those with not-detected (ND) viraemia. Of note, a linear trend (P = 0.006) was observed among virologically suppressed (LLV, DNQ and ND) patients. ND patients had higher mtDNA levels compared with LLV patients (P = 0.057). Moreover, mtDNA levels were inversely associated with HIV-RNA levels (Spearman's rho -0.191, P = 0.003) and directly associated with CD4+ counts (Spearman's rho 0.131, P = 0.046). CONCLUSIONS: Increased plasma mtDNA levels are associated with lower HIV-RNA levels and higher CD4+ cell counts. Among ART-suppressed patients, mtDNA levels were significantly higher in those with complete virological suppression (ND) than in those with LLV. These data suggest that plasma mtDNA levels might serve as a biomarker of residual HIV replication.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Pernas B, Rego-Pérez I, Tabernilla A, et al. Plasma mitochondrial DNA levels are inversely associated with HIV-RNA levels and directly with CD4 counts: potential role as a biomarker of HIV replication. J Antimicrob Chemother. 2017. PMID: 28961892. doi:10.1093/jac/dkx272

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。